DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 188 filers reported holding DENALI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,564 | -30.1% | 802,899 | 0.0% | 0.71% | -3.3% |
| Q2 2023 | $23,694 | +28.1% | 802,899 | 0.0% | 0.73% | -33.2% |
| Q1 2023 | $18,499 | -16.9% | 802,899 | +0.4% | 1.10% | -11.5% |
| Q4 2022 | $22,248 | -99.9% | 800,000 | +33.3% | 1.24% | +58.0% |
| Q3 2022 | $18,414,000 | +4.3% | 600,000 | 0.0% | 0.79% | -16.6% |
| Q2 2022 | $17,658,000 | -8.5% | 600,000 | 0.0% | 0.94% | +16.7% |
| Q1 2022 | $19,302,000 | -27.9% | 600,000 | 0.0% | 0.81% | +11.3% |
| Q4 2021 | $26,760,000 | +6.1% | 600,000 | +20.0% | 0.73% | +28.7% |
| Q3 2021 | $25,225,000 | -35.7% | 500,000 | 0.0% | 0.56% | -29.1% |
| Q2 2021 | $39,220,000 | +37.4% | 500,000 | 0.0% | 0.80% | +57.9% |
| Q1 2021 | $28,550,000 | -14.8% | 500,000 | +25.0% | 0.50% | -29.9% |
| Q4 2020 | $33,504,000 | +133.8% | 400,000 | 0.0% | 0.72% | +106.6% |
| Q3 2020 | $14,332,000 | +31.7% | 400,000 | -11.1% | 0.35% | +14.5% |
| Q2 2020 | $10,881,000 | +24.3% | 450,000 | -10.0% | 0.30% | -17.8% |
| Q1 2020 | $8,755,000 | +25.6% | 500,000 | +25.0% | 0.37% | +37.5% |
| Q4 2019 | $6,968,000 | +13.7% | 400,000 | 0.0% | 0.27% | +9.3% |
| Q3 2019 | $6,128,000 | -26.2% | 400,000 | 0.0% | 0.25% | -26.8% |
| Q2 2019 | $8,304,000 | -10.6% | 400,000 | 0.0% | 0.34% | -11.3% |
| Q1 2019 | $9,288,000 | -10.1% | 400,000 | -20.0% | 0.38% | -1.0% |
| Q4 2018 | $10,330,000 | -5.0% | 500,000 | 0.0% | 0.38% | +35.3% |
| Q3 2018 | $10,870,000 | +42.6% | 500,000 | 0.0% | 0.28% | +74.7% |
| Q2 2018 | $7,625,000 | -13.9% | 500,000 | +11.1% | 0.16% | +45.9% |
| Q1 2018 | $8,861,000 | +13.3% | 450,000 | -10.0% | 0.11% | -5.9% |
| Q4 2017 | $7,820,000 | – | 500,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |